A critical shortage of brain scanners in the UK is delaying diagnoses for dementia patients and potentially blocking access to breakthrough drugs that could slow disease progression, according to analysis by the Alzheimer's Society.

The UK has the lowest rate of MRI, CT, and PET scanners among 16 comparable developed economies. Furthermore, the machines that are available are unevenly distributed across the country, creating a "postcode lottery" for care. To match France, which ranks second-to-last, the UK would need an additional 1,800 scanners, the charity reports.

NHS figures indicate England has 1,472 MRI and CT scanners, equating to 23 per million people. However, this rate varies significantly, with some areas like Staffordshire and Stoke-on-Trent having only 13 scanners per million, while North Central London has 35 per million.

Brain scans are essential for diagnosing dementia by helping clinicians examine brain changes and rule out other causes for symptoms. They are also crucial for determining eligibility for new treatments such as lecanemab and donanemab. These drugs, which target the underlying causes of Alzheimer's disease and can delay progression by up to 8.3 years, are most effective in the early stages and require regular scans to monitor suitability.

Currently, these advanced therapies are only available privately in England, as the National Institute for Health and Care Excellence (NICE) has deemed them too costly for the NHS. The Alzheimer's Society warns that even if NICE's decision is overturned, the shortage of scanners would leave the NHS ill-equipped to administer these treatments, potentially denying patients valuable time and extended independence.

The charity highlights that only two-thirds of people living with dementia in England receive a formal diagnosis, and many face lengthy waits, missing the optimal window for treatment. The Alzheimer's Society advocates for a new target ensuring patients wait no more than 18 weeks for a diagnosis after GP referral to a specialist memory clinic.

Beyond machine availability, the UK also faces a 32% shortfall in consultant radiologists, the senior doctors who interpret scan images, according to a report by the Royal College of Radiologists. Without sufficient staff, increased equipment capacity will not translate into improved diagnostic capabilities.

The government has committed to doubling the number of CT and MRI scanners in England, with an increase of 125 machines already reported in the two years to March 2026. However, the Alzheimer's Society urges ministers to ensure these new scanners are distributed to address the existing diagnostic gaps across the country.

"An early and accurate diagnosis can help people understand what is happening, access the right support and plan for the future," said Michelle Dyson, chief executive of Alzheimer's Society. "As new treatments emerge, getting the right diagnosis is vital, as an accurate diagnosis is key to confirming eligibility. But buying machines alone isn't enough. We need more radiologists employed to use them and we need to make sure people living with dementia benefit from access wherever they live. We cannot allow the next era of dementia diagnosis and treatment to be determined by your postcode – people with dementia deserve better than that."

Cognitive assessments, medical history reviews, and cerebrospinal fluid tests are also part of the dementia diagnostic process. A Department of Health and Social Care spokesperson stated that the additional 125 scanners are equipped with AI technology to enhance patient throughput and reduce scan times, contributing to a record number of diagnostic scans and tests delivered in September.